Experience

INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS

• France
• Research Services
• 1 - 100 Employee

• Global Program Leader Apoptosis Haematology R&D

  • Mar 2021 - Present

  Lead on the global small molecules development strategy through the management of senior experts of the Core Team with respect to clinical strategy, competitive inteligence, quality, timelines, cost and performance Lead on the global small molecules development strategy through the management of senior experts of the Core Team with respect to clinical strategy, competitive inteligence, quality, timelines, cost and performance



Servier

• France
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Global Project Leader Apoptosis Haematology/Oncology R&D

  • Apr 2019 - Mar 2021

  Lead on the global development through the management of senior experts of the Core team with respect to quality, timelines, cost and performance

• Associate Clinical Project Director CART cell therapy

  • Sep 2017 - Mar 2019

  Contribution in building and implementation of the development strategy with respect to quality, timelines, cost and performance accros the allogeneic CAR-T cells program

• Senior Clinical Project Manager, Oncology R&D

  • Jun 2014 - Aug 2017

  Development of a global strategy with different indications per territory, follow-up on the clinical program including clinical studies ph I/II, scientific advice with CA, regulatory documents. Internal standards development and PIP coordination.

• International Clinical Project Manager, Oncology R&D

  • 2007 - 2014

  International clinical trials: Management of a clinical team (3 people) for phase I/II clinical trials, Leadership of the Scientific Advisory Boards, generation of Protocols and Amendments, Investigator's Brochures, Data review, clinical study reports, abstracts, manuscripts, posters and other communication material, Scientific and medical support to investigators, Health Authorities, ECs and CROs.Transversal activities: Development of standards for eCRF and a standard statistical analysis plan for phase I studies in oncology Show less

• Medical Writing Project Manager, Medical Writing Department

  • 2001 - 2007

  Phase II and III clinical trials data review, statistical analysis plan validation, Results interpretation, writing of clinical study reports and Overall Safety Assessment reports

• Quality Control Specialist, Medical Writing Department

  • 2000 - 2001


KARGER edition
• Assistant to the Editor in Chief, “Neuroendocrinology”

  • 1998 - 1999

Inserm
• France
• Research Services
• 700 & Above Employee
• PhD Research scientist in Neuroscience

  • 1993 - 1997

Faculty of Medicine, Wroclaw, Poland
• Research scientist in Neuroscience and Teacher, Department of Biophysics

  • 1988 - 1992